Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

The Original Article was published on 11 September 2018

Nature Reviews Neuroscience (2018) https://doi.org/10.1038/s41583-018-0055-7 Published online 11 September 2018

In the originally published version of this article, the competing interests statement indicated that the authors had no competing interests; however, this statement was incorrect. The statement should have read as follows: ‘M.H. receives a consultation fee from IFM Therapeutics, LLC for consultations regarding the pathogenesis and interventional strategies of neurodegenerative disease. E.L. is a scientific co-founder and consultant to IFM Therapeutics. R.M.M. declares no competing interests.’ This error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael T. Heneka.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Heneka, M.T., McManus, R.M. & Latz, E. Author Correction: Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 20, 187 (2019). https://doi.org/10.1038/s41583-019-0137-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41583-019-0137-1

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing